trial

Evaluation of QTc Interval by Continuous Holter ECG Recording in Antipsychotic Drug-treated Patients With Schizophrenia

NCTId NCT00178958
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 70
Sponsored by Northwestern University
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
70
Study type
Interventional
Allocation
Non Randomized
Model
Single Group
Masking
None
Start
2003-08
Primary completion
—
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Holter Monitor

Sponsors

Northwestern UniversityLead Sponsor

Investigators

1
Herbert Y Meltzer, M.D.Principal Investigator

Sites

0 total

Facts & assertions

3 sourced
Enrollment
70
Phase
NA
Status
COMPLETED
relationships
The graph out of here
drug
Holter Monitor
drug
lead_sponsor
Northwestern University
company
indication
Bipolar Disorder
indication
Schizophrenia
indication
Bipolar Disorder
indication
investigator
Herbert Y Meltzer, M.D.
person